NCT03048019View on ClinicalTrials.gov

Antiplatelet Effects of Tirofiban vs. Cangrelor N-STEMI Patients Undergoing Percutaneous Coronary Intervention

TerminatedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

August 23, 2017

Primary Completion Date

June 27, 2019

Study Completion Date

June 27, 2019

Conditions
Non-ST Elevation Myocardial Infarction (NSTEMI)
Interventions
DRUG

Tirofiban

Patients will receive Tirofiban during the PCI procedure

DRUG

Cangrelor

Patients will receive Cangrelor during the PCI procedure

Trial Locations (1)

22042

Inova Health Care System, Falls Church

Sponsors
All Listed Sponsors
lead

Inova Health Care Services

OTHER